Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RF Microneedle Therapy Maintains the Treatment Effect of Melasma: A 32-week, Prospective, Randomized Split-face Study

NCT05710068 is registered in ClinicalTrials.gov with Ajou University School of Medicine as lead sponsor.

NCT NCT05710068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05710068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RF Microneedle Therapy Maintains the Treatment Effect of Melasma: A 32-week, Prospective, Randomized Split-face Study
Lead sponsor
Ajou University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2021
Completion date
September 1, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pigmentation, pigmentation disorder